| 000 | 01715 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517014613.0 | ||
| 264 | 0 | _c20150625 | |
| 008 | 201506s 0 0 eng d | ||
| 022 | _a1872-7786 | ||
| 024 | 7 |
_a10.1016/j.cbi.2015.01.028 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNirogi, Ramakrishna | |
| 245 | 0 | 0 |
_aEvaluation of metabolism dependent inhibition of CYP2B6 mediated bupropion hydroxylation in human liver microsomes by monoamine oxidase inhibitors and prediction of potential as perpetrators of drug interaction. _h[electronic resource] |
| 260 |
_bChemico-biological interactions _cMar 2015 |
||
| 300 |
_a9-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBupropion _xmetabolism |
| 650 | 0 | 4 |
_aClorgyline _xpharmacology |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP2B6 _xmetabolism |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP2B6 Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aGlutathione _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydroxylation |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 | _aKinesics |
| 650 | 0 | 4 |
_aMicrosomes, Liver _xdrug effects |
| 650 | 0 | 4 |
_aMonoamine Oxidase Inhibitors _xchemistry |
| 650 | 0 | 4 |
_aPargyline _xpharmacology |
| 650 | 0 | 4 |
_aPhenelzine _xpharmacology |
| 650 | 0 | 4 |
_aSelegiline _xpharmacology |
| 700 | 1 | _aPalacharla, Raghava Choudary | |
| 700 | 1 | _aMohammed, Abdul Rasheed | |
| 700 | 1 | _aManoharan, Arunkumar | |
| 700 | 1 | _aPonnamaneni, Ranjith Kumar | |
| 700 | 1 | _aBhyrapuneni, Gopinadh | |
| 773 | 0 |
_tChemico-biological interactions _gvol. 230 _gp. 9-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.cbi.2015.01.028 _zAvailable from publisher's website |
| 999 |
_c24599511 _d24599511 |
||